###### Significance of this study

What is already known about this subject?
=========================================

-   Patients with primary aldosteronism (PA) have an increased rate of cardiovascular events and renal damage, metabolic syndrome (MS) and diabetics in addition to hypertension.

-   Aldosterone levels positively correlate with visceral adipose tissue area in healthy women, and 24-hours urinary aldosterone levels were also found to correlate with subcutaneous, not visceral, adipose tissue area in obese healthy individuals.

What are the new findings?
==========================

-   Patients with PA has smaller visceral fat area (VFA) than their essential hypertension (EH) controls, and VFA increased after adrenalectomy.

-   Smaller VFA and shorter duration of hypertensive latency could predict completely cure of hypertension after surgery.

How might these results change the focus of research or clinical practice?
==========================================================================

-   Chronic excess aldosterone will relate to decreased size of adipose tissue.

-   VFA and duration of hypertension at diagnosis were related to long-term outcome after adrenalectomy. The complex interplay between aldosterone, adipose tissue, metabolic syndrome and subsequent diabetics in patients with PA needs further clarification.

Introduction {#s1}
============

Primary aldosteronism (PA), a state of aldosterone excess due to the autonomous production of aldosterone by adrenal adenoma or hyperplasia of the zona glomerulosa, affects 5%--13% of patients with hypertension.[@R1] Patients with PA have an increased rate of cardiovascular events and renal damage, in addition to hypertension.[@R2] Previous studies showed impaired glucose homeostasis and insulin resistance (IR) in patients with PA, leading to increased prevalence of metabolic syndrome (MS),[@R4] which could be improved after adrenalectomy.[@R4]

Visceral adiposity, which is the accumulation of adipose tissue within the abdomen, is associated with cardiovascular disease MS and diabetics.[@R8] Adipose tissue has been proposed to play a pivotal role in the pathogenesis of glucose metabolism disturbances in patients with PA.[@R9] However, the gene expression of insulin signaling molecular from visceral adipose tissue is similar between APA and non-functioning adrenal adenoma, and thus the role of insulin sensitivity attributing to excess aldosterone is not conclusive in patients with aldosterone-producing adenoma (APA).[@R10] However, aldosterone is an important contributor to adipogenesis via the non-genomic action of the mineralocorticoid receptor (MR),[@R11] and evidence demonstrates that human adipocytes could also stimulate secretion of aldosterone and vice versa.[@R12] Aldosterone levels positively correlate with visceral adipose tissue area in healthy women,[@R14] and 24-hour urinary aldosterone levels were also found to correlate with subcutaneous, not visceral, adipose tissue area in obese healthy individuals.[@R15] However, the role of visceral adipose tissue and the outcome of patients with APA after surgery has not been well investigated. This study aimed to evaluate the role of visceral adiposity associated with clinical success after surgery in patients with APA.

Subjects and methods {#s2}
====================

Ethics statement {#s2-1}
----------------

All participants signed the informed consent form before their enrollment in the research. The study performed all methods in agreement with approved guidelines.

Patient selection and PA identification {#s2-2}
---------------------------------------

This study was conducted on patients with APA who received adrenalectomies from January 2011 to January 2013 and followed up until January 2014. The Taiwan primary aldosteronism investigators (TAIPAI) database was established for quality affirmation at two medical centers and their three affiliated hospitals and at two local hospitals from different cities in Taiwan.[@R16] All antihypertensive medications were discontinued for at least 21 days before performing confirmatory tests. Diltiazem and/or doxazosin were administered to manage distinctly high blood pressure when needed.[@R19] PA was confirmed in patients with an elevated aldosterone after the saline infusion test, followed by imaging studies for subtype identification. PA confirmation and subtype identification were performed in hypertensive patients according to the standard protocol of the TAIPAI and aldosteronism consensus of Taiwan,[@R20] including adrenal venous sampling and NP-59 scintigraphy with single-photon emission computed tomography (SPECT-CT) imaging.[@R18] Patients who were diagnosed with familiar hyperaldosteronism type I/Glucocorticoid Remediable Aldosteronism (GRA) were excluded using long-range PCR, as described previously.[@R21]

Laboratory measurements {#s2-3}
-----------------------

We collected the baseline data of enrollees, including age, height, weight, waist circumference, blood pressure and biochemistry profile. Estimated glomerular filtration rate was ascertained by Modification of Diet in Renal Disease.[@R22] Plasma aldosterone was measured by radioimmunoassay using a commercial kit (Aldosterone Maia Kit; Biochem Immunosystems, Bologna, Italy). The lowest detectable concentration of aldosterone was 10.0 pg/mL, and the normal range of aldosterone was 70--350 pg/mL in the upright position. Plasma renin activity (PRA) was identified as the generation of angiotensin I by in vitro analysis using a commercially available radioimmunoassay kit (Stillwater, Minnesota, USA). The normal range of PRA was 2.63±1.32 ng/mL/hour in the upright position. The mean SD intra-assay and interassay coefficients of variation for the PRA assay were 1.9 (5.0%) and 4.5 (5.2%), respectively. The homeostasis model assessment of insulin resistance (HOMA-IR) was estimated using the following formula: HOMA-IR=HOMA-IR: insulin (μU/mL)×glucose (mg/dL) / 405.[@R23]

Measurement of abdominal adipose tissue by CT {#s2-4}
---------------------------------------------

Imaging of each patient was performed with a 16-slice multidetector CT scanner (LightSpeed 16, GE Healthcare, Milwaukee, Wisconsin, USA). Image analysis software (ImageJ, V.1.43q; National Institutes of Health, Bethesda, Maryland, USA) was used for the subcutaneous and visceral abdominal adipose tissue areas at the level of the umbilicus, after applying threshold with an attenuation range between −50 to −250 Hounsfield units. The adipose tissue areas were presented in mm.[@R2] Subcutaneous fat area (SFA) was defined as the adipose tissue between the skin and muscle. Intra-abdominal tissue with density in the fat attenuation range was identified as visceral fat area (VFA) by CT as previously reported.[@R24]

Adrenalectomy {#s2-5}
-------------

All of the operations were accomplished adopting the lateral transperitoneal approach and were executed by experienced laparoscopic surgeons to ensure that the principles of adrenal gland surgery were strictly followed.[@R25]

Outcome measures {#s2-6}
----------------

Patients were followed up monthly for the first 3 months after the operation, and every 3 months from then on.

We deﬁned the clinical outcome according to the Primary Aldosteronism Surgery Outcome consensus as complete clinical success indicating normal BP without antihypertensive medication at 1 year later after surgery.[@R26]

Statistical analysis {#s2-7}
--------------------

The correlations of VFA and SFA with plasma aldosterone, renin, aldosterone--renin ratio (ARR) and the other clinical parameters were examined using Pearson's correlation coefficients. The variables independently associated with VFA and SFA were identified by stepwise linear regression analysis. A normal distribution was attained by appropriate transformations of the skewed variables, including aldosterone, renin, ARR, VFA and SFA.

Binary logistic regression analysis with a stepwise variable selection procedure was adopted using available variables to identify the important factors associated with postoperative complete clinical success. The significance levels for entry and for stay were conservatively set at 0.15. The goodness-of-fit (GOF) of the fitted multiple logistic regression model was examined by the estimated area under the receiver operating characteristic curve, the adjusted generalized R^2^ and the Hosmer-Lemeshow GOF test. A generalized additive model (GAM) that incorporated the subject-specific random effects was plotted then adjusted for the duration of hypertension to diagnosis of PA.[@R27]

All continuous variables were reported as means±SDs (with 95% CIs as appropriate), and categorical variables were reported as frequencies or percentages. A p value of \<0.05 was considered statistically significant. The statistical analyses were performed using SPSS software, V.22.0, and R software, V.2.8.1 (Free Software Foundation, Inc., Boston, Massachusetts).

Results {#s3}
=======

Patient characteristics {#s3-1}
-----------------------

During the study period, 100 APA patients (42 males; aged 49.3±11.8 years) who had received adrenalectomy were identified ([table 1](#T1){ref-type="table"}). Furthermore, 41 patients with EH (17 males; 24 females) whose age, sex, body mass index and systolic blood pressure were matched and enrolled as a control group. The baseline characteristics before surgery were listed in [table 1](#T1){ref-type="table"}.

###### 

Characteristics of patients with APA and EH at diagnosis

  ---------------------------------------------------------------
                             EH           APA           P value
  -------------------------- ------------ ------------- ---------
  Male                                                  

   Female (%)                24 (58.5)    58 (58.0)     0.999

   Male(%)                   17 (41.5)    42 (42.0)     

  Age (years)                53.1±12.4    49.3±11.8     0.090

  Waist circumference (cm)   84.1±11.6    81.1±10.4     0.167

  BMI (kg/m^2^)              24.9±3.6     25.0±3.8      0.919

  sBP (mm Hg)                151.0±17.5   154.1±22.9    0.735

  Log ald (ng/dL)            3.4±0.7      3.9±0.6       \<0.001

  Log renin (ng/mL/hour)     −0.5±1.1     −1.9±1.9      \<0.001

  Log (ARR)\                 3.9±1.4      5.8±2.0       \<0.001
  (ng/dL per ng/mL/hour)                                

  Potassium (mmol/L)         4.2±0.4      3.6±0.7       \<0.001

  Cholesterol (mg/dL)        192.4±33.4   190.2±34.0    0.671

  Triglyceride (mg/dL)       108.4±58.1   125.4±120.2   0.938

  HOMA-IR index              3.2±6.0      2.6±4.5       0.152

  eGFR (mL/min/1.73 m^2^)    90.3±28.0    86.8±29.4     0.409

  Duration of HTN (years)    5.8±6.3      7.8±7.6       0.100

  Log VFA (mm^2^)            9.3±0.5      9.1±0.5       0.021

  Log SFA (mm^2^)            9.8±0.4      9.7±0.4       0.117
  ---------------------------------------------------------------

Data are expressed as mean±SD unless otherwise indicated.

APA, aldosterone-producing adenoma; ARR, aldosterone--renin ratio; BMI, body mass index; eGFR, estimate glomerular filtration rate; EH, essential hypertension; HOMA-IR, homeostasis model assessment for insulin resistance; HTN, hypertension; sBP, systolic blood pressure; SFA, subcutaneous fat area; VFA, visceral fat area.

APA patients had smaller VFA (p=0.021), lower levels of renin (p\<0.001) and potassium (p\<0.001) and higher level of aldosterone (p\<0.001) and ARR (p\<0.001) than EH patents ([table 1](#T1){ref-type="table"}).

Factors that correlated with VFA in patients with PA {#s3-2}
----------------------------------------------------

Multiple linear regression showed that age (p=0.001), BMI (p\<0.001), waist circumference (b=0.020, p\<0.001), and the duration of hypertension (b=−0.015, p\<0.001) were independent factors related to VFA in patients with APA ([table 2](#T2){ref-type="table"}). Furthermore, after adjusting the covariables, the non-linear GAM regression plot showed a trend for inverse association between log VFA and high 24-hour urine aldosterone level, especially when it was \>29.3 µg/day ([online supplementary figure S1](#SP1){ref-type="supplementary-material"}).
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###### 

Correlations of VFA of APA patients with plasma aldosterone, renin, ARR and other clinical variables examined using Pearson's correlation coefficients

  -------------------------------------------------------------------------
                             Univariate   Multivariate            
  -------------------------- ------------ -------------- -------- ---------
  Age (years)                0.278        0.001          0.015    0.001

  BMI (kg/m^2^)              0.522        \<0.001        0.056    \<0.001

  Waist circumference (cm)   0.655        \<0.001        0.020    \<0.001

  sBP (mm Hg)                0.024        0.775          \_       \_

  Log ald (ng/dL)            −0.058       0.492          \_       \_

  Log renin (ng/mL/hour)     0.167        0.048          \_       \_

  log (ARR)\                 −0.168       0.047          \_       \_
  (ng/dL per ng/ml/hour)                                          

  Potassium (mmol/L)         0.216        0.010          \_       \_

  Cholesterol (mg/dL)        0.003        0.972          \_       \_

  Triglyceride (mg/dL)       0.193        0.022          \_       \_

  HOMA-IR index              0.191        0.024          \_       \_

  eGFR (mL/min/1.73 m^2^)    −0.241       0.004          −0.004   0.010

  Duration of HTN (years)    0.047        0.583          −0.015   0.020
  -------------------------------------------------------------------------

Independent risks predicting preoperative VFA of APA patients by multiple linear regression model.

APA, aldosterone-producing adenoma; ARR, aldosterone-renin ratio; BMI, body mass index; eGFR, estimate glomerular filtration rate; HOMA-IR, homeostasis model assessment for insulin resistance; HTN, hypertension; sBP, systolic blood pressure; VFA, visce fat area.

Factors that predicted cure of hypertension after adrenalectomy {#s3-3}
---------------------------------------------------------------

One year after adrenalectomy, 66 of 100 patients (66.0%) were completely cured of hypertension ([table 3](#T3){ref-type="table"}).

###### 

Characteristics of patients with APA at diagnosis categories by hypertensive status after adrenalectomy

  ---------------------------------------------------------------------------------------------------------
                             All patients\   Residual of hypertension\   Cure of hypertension\   P values
                             (n=100)         (n=34)                      (n=66)                  
  -------------------------- --------------- --------------------------- ----------------------- ----------
  Female (%)                 58 (58.0%)      13 (38.2%)                  45 (68.2%)              0.005

  Male (%)                   42 (42.0%)      21 (61.8%)                  21 (31.8%)              0.005

  Age (years)                49.3±11.8       53.3±12.4                   47.3±11.1               0.016

  Waist circumference (cm)   81.1±10.4       86.4±10.4                   78.4±9.4                \<0.001

  BMI (kg/m^2^)              25.0±3.8        26.1±3.5                    24.5±3.8                0.012

  sBP (mm Hg)                154.1±22.9      156.1±21.8                  153.1±23.5              0.298

  Log ald (ng/dL)            3.9±0.6         3.8±0.6                     4.0±0.6                 0.352

  Log renin (ng/mL/hour)     −1.9±1.9        −1.9±2.1                    −1.9±1.8                0.924

  Log (ARR)\                 5.8±2.0         5.7±2.1                     5.9±2.0                 0.859
  (ng/dL per ng/mL/hour)                                                                         

  Potassium (mmol/L)         3.6±0.7         3.8±0.5                     3.5±0.7                 0.018

  Cholesterol (mg/dL)        190.2±34.0      190.1±32.9                  190.3±34.9              0.839

  Triglyceride (mg/dL)       125.4±120.2     124.8±67.1                  125.7±140.4             0.123

  HOMA-IR index              2.6±4.5         3.2±5.7                     2.4±3.7                 0.184

  eGFR (mL/min/1.73 m^2^)    86.8±29.4       75.4±27.0                   92.6±29.0               0.002

  Duration of HTN (years)    7.8±7.6         10.4±7.6                    6.4±7.3                 0.004

  Log VFA (mm^2^)            9.1±0.5         9.4±0.4                     8.9±0.5                 \<0.001

  Log SFA (mm^2^)            9.7±0.4         9.8±0.3                     9.6±0.4                 0.070
  ---------------------------------------------------------------------------------------------------------

Data are expressed as mean±SD unless otherwise indicated.

APA, aldosterone-producing adenoma; ARR, aldosterone-renin ratio; BMI, body mass index; eGFR, estimate glomerular filtration rate; HOMA-IR, homeostasis model assessment for insulin resistance; HTN, hypertension; sBP, systolic blood pressure; SFA, subcutaneous fat area; VFA, visceral fat area.

The GAM regression model ([figure 1](#F1){ref-type="fig"}) showed that APA patients with log VFA smaller than 9.2 had a clinical advantage in complete clinical success. Smaller VFA, identified as log VFA \<9.2, has a sensitivity of 0.742 (95% CI 0.620 to 0.842); specificity of 0.676 (95% CI 0.495 to 0.826); positive predictive value of 0.817 (95% CI 0.696 to 0.905); and negative predictive value of 0.575 (95% CI 0.409 to 0.730) to complete clinical success. Therefore, smaller Log VFA (OR=0.065; 95% CI 0.018 to 0.231; p*\<*0.001) and shorter duration of hypertension to PA diagnosis (OR=0.919; 95% CI 0.860 to 0.981; p=0.011) could independently predict the cure of hypertension. The model had well calibrated, Hosmer-Lemeshow GOF test (p=0.821). Because the possibility of interaction between BMI and VFA, six subgroups were constructed by stratified BMI into tertile values and combined with log VFA, which was either greater or smaller than 9.2 ([online supplementary figure S2](#SP2){ref-type="supplementary-material"}). We compared the ORs and 95% CIs of each subgroup for predicting the cure of hypertension. The size of VFA could predict the cure of hypertension, yet stratification into tertiles according to BMI could not.
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![APA patients with log VFA smaller than 9.2 had a clinical advantage in clinical complete success. GAM plot for the probability of cure of hypertension against log VFA level of APA patients at index date incorporating the subject-specific random effects expressed as the logarithm of the odds (logit). The probability of outcome events was constructed with hypertensive duration have an average of zero over the range of the data, that is, log VFA=9.2. The *dashed lines* indicate approximated point-wise 95% CI. Data are expressed as mean±SD unless otherwise indicated. APA, aldosterone-producing adenoma; GAM, generalized additive model; HTN, hypertension; VFA, visceral fat area.](bmjdrc-2019-001153f01){#F1}

Change of VFA and SFA after adrenalectomy {#s3-4}
-----------------------------------------

Twenty patients with APA (9 men, 11 women) underwent sequential CT at 6 months after adrenalectomy. The mean differences of log pre-adrenalectomy VFA versus log postadrenalectomy VFA was −0.069 (95% CI −0.137 to 0.002) and log preadrenalectomy SFA versus log postadrenalectomy SFA was −0.059 (95% CI −0.142 to 0.023), respectively. The log VFA (p=0.045) but not the log SFA (p=0.150) augmented after adrenalectomy ([figure 2](#F2){ref-type="fig"}).

![Log postoperation VFA (after adrenalectomy) and log preoperation VFA (before adrenalectomy) of 20 patients with APA. APA, aldosterone-producing adenoma; VFA, visceral fat area.](bmjdrc-2019-001153f02){#F2}

Discussion {#s4}
==========

The main finding of this multicenter study was that patients with PA had smaller VFA than their EH controls and that VFA increased after adrenalectomy. Smaller VFA and shorter duration of hypertensive latency could predict the complete cure of hypertension after surgery. Smaller VFA had a high discriminative power to complete clinical success with cure of hypertension. In this study, we showed that small VFA was associated with clinical complete success after surgery, even after adjustment for BMI. Previous study showed that PAC was positively correlated with visceral adipose tissue in non-PA population,[@R14] and 24-hour urinary aldosterone excretion was also found positively correlated with SFA but not with the VFA of obese non-PA individuals.[@R15] Our study further revealed that a relatively high urinary aldosterone level was correlated with smaller VFA in patients with APA.

Comparison of VFA in patients with APA and EH {#s4-1}
---------------------------------------------

There is a two-way interaction between adipose tissue and aldosterone.[@R30] Previous evidence demonstrated that human adipocytes produce mineralocorticoid-releasing factors that stimulated secretion of aldosterone.[@R12] Adipocytes may contribute to excess aldosterone synthesis and secretion, involving both generalized stimulation of the renin--angiotensin--aldosterone system and, independently, production and release of products that could stimulate local or adrenal aldosterone synthesis.[@R31] In addition, aldosterone acts via non-genomic action on the MR and induces peroxisome proliferator activated receptor gamma mRNA expression, therefore promoting white adipose cell differentiation and leading to a proadipogenic effect on human adipocytes in vivo.[@R11] However, evidence for the direct effect of chronic excess aldosterone among patients with PA on visceral adipose tissue is scarce. When adipose cells, 3T3-L1 and 3T3-F442A, were exposed to different doses of aldosterone, the proadipogenic effect of aldosterone was attenuated by higher doses of aldosterone.[@R13] Additionally, a recent study that investigated perirenal adipose tissue, which is another region of visceral adipose tissue in the retroperitoneal cavity, and found interleukin 6 (IL-6), Tumor Necrosis Factor-α (TNF-α) protein and mRNA were significantly higher in the APA group than in the Normotension (NT) and EH groups.[@R32] The authors of that study proposed that excess aldosterone in vivo may be related to increased inflammation in perirenal adipose tissue.[@R32]

Importantly, the markers of fibrosis such as fibronectin and collagen I protein were reported to be higher in the perirenal adipose tissue in patients with APA than in NT and EH patients,[@R32] suggesting that aldosterone in patients with APA may cause perirenal adipose tissue impairment and lead to inflammation and fibrosis. Previous studies demonstrated an inverse correlation between fibrosis and adipocyte area.[@R33] Taken together, it would be reasonable to speculate that hypersecretion of aldosterone increases tissue fibrosis and attenuates the size of adipocytes in vivo. Moreover, sympathetic overactivity was found in patients with PA,[@R35] and it might contribute to more energy consumption as well as lead to decreasing size of adipose tissue. Based on the aforementioned finding, it may be plausible to assume that patients with PA, with chronic excessive aldosterone, would have a smaller VFA compared with patients with EH as observed in our study.

Smaller VFA correlated with longer duration of hypertension to the diagnosis in patients with PA {#s4-2}
------------------------------------------------------------------------------------------------

Our results showed that the duration of hypertension was negatively correlated with VFA at PA diagnosis, and smaller VFA is correlated with longer duration of hypertension to diagnosis in patients with PA. Compared with non-PA obese population, patients with PA had chronic excessive exposure to autonomously produced aldosterone; this might have different effects on adipose tissue as their dosages are different from non-PA population. This speculation might explain why our result showed longer term of excess aldosterone in patients with APA presented with smaller VFA. Among the population of non-PA, one study found the positive correlation between serum aldosterone levels and visceral obesity in healthy women[@R14]; however, other studies from a large community-based sample of non-PA patients[@R36] and a recent study of APA patients,[@R37] in agreement with our result, reveal that visceral adipose tissue was not associated with plasma aldosterone levels.

Adipose tissue, in particular visceral fat, secretes several adipokines that cause inflammation, energy balance and insulin resistant.[@R38] This positive correlation between VFA and insulin resistance (HOMA-IR) in non-PA led to the detrimental effect on glucose and lipid metabolism. However, our investigation showed no correlation between VFA and HOMA-IR in patients with PA. We suggested that other factors might play more crucial roles than VFA as the causes of impaired glucose homeostasis and IR in patients with PA. Several factors have been proposed in previous studies. First, increased inflammation, oxidative stress, and a decreased beta cell function can be precipitated by increased aldosterone levels.[@R39] Second, the increased aldosterone in PA caused IR in peripheral tissues.[@R10] Third, hypokalemia impaired insulin secretion.[@R43]

Predictive factors for clinical complete success after adrenalectomy in patients with APA {#s4-3}
-----------------------------------------------------------------------------------------

Our result showed that smaller VFA was a strong predictor of clinical complete success after adrenalectomy ([table 3](#T3){ref-type="table"}). It raises the possibility of using VFA and duration of hypertension to diagnosis PA as predictors in determining long-term outcome after adrenalectomy. Mounting evidence suggested that excess weight gain and visceral obesity were the major causes of hypertension.[@R46] Thus, patients with APA who have large VFA might carry a concomitant obesity-related hypertension and have residual hypertension even after adrenalectomy. We suggested that APA patients with increased visceral adipose tissue following adrenalectomy should be evaluated and treated with raised awareness in order to achieve ideal glucose control and prevent potential complication.

Moreover, our study found shorter duration of hypertensive latency before PA diagnosis was a predictor of complete clinical cure of hypertension after adrenalectomy. In patients with PA, longer duration of hypertension is likely to be long-term exposure to excess aldosterone, and this phenomenon might contribute to endothelial dysfunction, vascular damage and arteriolosclerosis and may be related to cardiac remodeling and vascular hypertrophy.[@R47] We speculated that patients with an APA as the sole cause of hypertension have factors that decrease VFA thus respond more completely to APA removal than patients who may have acquired an APA in addition to other pathologies causing hypertension.

Of note, CTs are readily obtained in almost every diagnosed patients with PA before lateralization. Compared with BMI, CT can quantify fat distribution and measure adiposity more accurately,[@R48] while BMI cannot differentiate body fat from fat-free mass. Our subgroup analysis ([online supplementary figure S2](#SP2){ref-type="supplementary-material"}) demonstrated that the size of VFA, but not BMI, could predict the cure of hypertension even patients with APA were stratified in to tertiles according to BMI. Additionally, for those patients with APA who has lower BMI, APA patients with smaller VFA showed higher possibility for cure of hypertension after adrenalectomy. Finally, our study also revealed that VFA significantly increased after adrenalectomy. Similarly, Giacchetti *et al* [@R49] reported that the body weight significantly increased in APA patients after adrenalectomy. This might lead to the attenuation of chronic excess aldosterone, which is related to decreased size of adipose tissue after adrenalectomy.[@R33]

Study limitations {#s4-4}
-----------------

Our study had the following limitations. First, our study was an observational study; therefore, the associations were not prospective, and causality cannot be inferred. The observational nature of this study was an intrinsic limitation because the lack of randomization precluded a definite investigation of treatment advantages. Observation data may currently remain the best available evidence to observe the association of PA with VFA. Moreover, this was a correlation study with no biological experimental evidence to validate the correlations or to state the role of aldosterone on MR of adipose tissue in patients with PA. Furthermore, as we did not perform 1 mg Dexamethasone Suppression Test (DST) for all patients in this study, we could not completely exclude the possibility of the inclusion of patients with autonomous cosecretion of cortisol. One potential problem is the correlation between the cross-sectional areas of VFA in a single slice and the VFA volume quantified with multiple slices has different; nevertheless, strong correlations are developed regardless of sample size.[@R48] Future elegant research would need to focus on further delineation of the complex interplay between aldosterone and adipose tissue in a larger sample size of patients with PA, as well as to examine the correlation of plasma aldosterone levels and visceral adipose tissue in patients with PA.

Conclusion {#s5}
==========

In this study, we found a negative association between relatively high urine aldosterone level and VFA that was calculated from abdominal CT in patients with APA. Patients with APA had smaller VFA than EH patients and VFA could increase after surgery. Smaller VFA and shorter duration of hypertension could predict the complete clinical cure of hypertension after adrenalectomy. These results raised the possibility that VFA and duration of hypertension at diagnosis were related to long-term outcome after adrenalectomy. The complex interplay between aldosterone, adipose tissue and subsequent diabetics in patients with PA needs further clarification.
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